Aigen Investment Management, LP Novavax Inc Transaction History

Aigen Investment Management, LP

  • $487 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022
SELL
$69.73 - $142.9 $95,460 - $195,630
-1,369 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$134.56 - $217.97 $184,212 - $298,400
1,369 New
1,369 $247,000
Q3 2020

Nov 06, 2020
SELL
$79.44 - $178.51 $414,120 - $930,572
-5,213 Closed
0 $0
Q2 2020

Aug 10, 2020
BUY
$13.86 - $83.61 $72,252 - $435,858
5,213 New
5,213 $435,000

Others Institutions Holding NVAX

# of Institutions
291
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $704M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email